Trademark: 87006020
Word
RIAVAX
Status
Registered
Status Code
700
Status Date
Tuesday, October 27, 2020
Serial Number
87006020
Registration Number
6182355
Registration Date
Tuesday, October 27, 2020
Mark Type
4000
Filing Date
Tuesday, April 19, 2016
Published for Opposition
Tuesday, August 11, 2020

Trademark Owner History
Sangjae KIM - Original Registrant
GemVax & KAEL Co., LTD. - Original Registrant

Classifications
3 Anti-aging cosmetic preparations, namely, anti-aging cleanser, anti-aging cream, anti-aging moisturizer, anti-aging toner, non-medicated anti-aging serum; non-medicated scalp treatment cream; massage creams, massage gels other than for medical purposes, massage lotions, massage oils; moisturizing body lotions, moisturizing creams, moisturizing preparations for the skin, moisturizing solutions for the skin, facial moisturizers; cosmetic sunscreen preparations, foams containing cosmetics and sunscreens, sun block, sun block preparations, sunscreen creams, sunscreen preparations; anti-wrinkle creams; wrinkle removing skin care preparations; wrinkle resistant cream; wrinkle-minimizing cosmetic preparations for topical facial use; hair creams; hair tonics; non-medicated hair restoration lotions; non-medicated hair serums; non-medicated hair treatment preparations for cosmetic purposes; cosmetic preparations for the care of mouth and teeth; teeth cleaning lotions; teeth whitening kit; facial beauty masks; facial masks; foot masks for skin care; gel eye masks; mask pack for cosmetic purposes; skin masks; skin moisturizer masks; essential oils; essential oils for food flavorings; essential oils for flavoring beverages; antibacterial skin soaps; antiperspirant soap; body cream soap
5 Food for babies; lacteal flour for babies; medicated supplements for foodstuffs for babies; powdered milk for babies; pharmaceutical preparations for wounds; pharmaceutical products for the prevention and treatment of cancer; anti-cancer preparations; vaccine for the prevention and treatment of cancer; adjuvants for use with vaccines for the prevention and treatment of cancer; human vaccine preparations for the prevention and treatment of cancer; oral vaccine preparations for the prevention and treatment of cancer; vaccine preparations for the prevention and treatment of cancer; pharmaceutical and veterinary preparations, namely, veterinary vaccines, nucleic acid sequences and chemical reagents for medical and veterinary purposes, enzyme preparations for veterinary purposes; dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; dietary supplements; dietary supplements for human consumption; nutritionally fortified beverages for medical purposes; pharmaceutical agents for epidermis; protein dietary supplements; diet capsules; dermatological pharmaceutical products; medicated cleansers for skin and wounds; medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; antiseptics; nutraceuticals for use as dietary supplements; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; diagnostic agents, preparations and substances for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic reagents for medicinal use
42 Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines for the prevention and treatment of cancer; pharmaceutical research and development; medical research services in the field of cancer; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; cosmetics research; scientific research consulting in the field of cosmetics; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; providing information on the subject of scientific research in the field of biochemistry and biotechnology; development of new technology for others in the field of biotechnology; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; biotechnology research; genetic testing for scientific research purposes; genetic testing of laboratory animals for research purposes; scientific research in the field of genetics and genetic engineering; chemistry consultation in the field of pharmacology; biochemical laboratory analysis in the field of chemistry; biochemical laboratory research in the field of chemistry; biochemical research in the field of chemistry; all of the foregoing for the prevention and treatment of cancer

Trademark Events
Oct 27, 2020
Registered-Principal Register
Aug 11, 2020
Official Gazette Publication Confirmation E-Mailed
Aug 11, 2020
Published For Opposition
Jul 22, 2020
Notification Of Notice Of Publication E-Mailed
Jul 8, 2020
Law Office Publication Review Completed
Jul 1, 2020
Approved For Pub - Principal Register
Jun 30, 2020
Examiner's Amendment Entered
Jun 30, 2020
Notification Of Examiners Amendment E-Mailed
Jun 30, 2020
Examiners Amendment E-Mailed
Jun 30, 2020
Examiners Amendment -Written
Jun 30, 2020
Previous Allowance Count Withdrawn
Jun 30, 2020
Case Returned To Examination
Jun 30, 2020
Notice Of Allowance Cancelled
Mar 17, 2020
Attorney Review/Decision On Amendment Required
Mar 17, 2020
Petition To Director - Change Basis - Granted
Mar 17, 2020
Assigned To Petition Staff
Jan 28, 2020
Teas Petition To Amend Basis Received
Jan 11, 2020
Notice Of Approval Of Extension Request E-Mailed
Jan 9, 2020
Extension 4 Granted
Jan 9, 2020
Extension 4 Filed
Jan 9, 2020
Teas Extension Received
Jun 15, 2019
Notice Of Approval Of Extension Request E-Mailed
Jun 13, 2019
Extension 3 Granted
Jun 13, 2019
Extension 3 Filed
Jun 13, 2019
Teas Extension Received
Dec 15, 2018
Notice Of Approval Of Extension Request E-Mailed
Dec 14, 2018
Extension 2 Granted
Dec 14, 2018
Extension 2 Filed
Dec 14, 2018
Teas Extension Received
Jul 7, 2018
Notice Of Approval Of Extension Request E-Mailed
Jul 5, 2018
Extension 1 Granted
Jul 5, 2018
Extension 1 Filed
Jul 5, 2018
Teas Extension Received
Jul 5, 2018
Teas Change Of Correspondence Received
Jan 9, 2018
Noa E-Mailed - Sou Required From Applicant
Nov 14, 2017
Official Gazette Publication Confirmation E-Mailed
Nov 14, 2017
Published For Opposition
Oct 25, 2017
Notification Of Notice Of Publication E-Mailed
Oct 10, 2017
Approved For Pub - Principal Register
Sep 29, 2017
Examiner's Amendment Entered
Sep 29, 2017
Notification Of Examiners Amendment E-Mailed
Sep 29, 2017
Examiners Amendment E-Mailed
Sep 29, 2017
Examiners Amendment -Written
Jul 24, 2017
Notification Of Non-Final Action E-Mailed
Jul 24, 2017
Non-Final Action E-Mailed
Jul 24, 2017
Non-Final Action Written
Jun 27, 2017
Lie Checked Susp - To Atty For Action
Jun 27, 2017
Assigned To Lie
Dec 9, 2016
Notification Of Letter Of Suspension E-Mailed
Dec 9, 2016
Letter Of Suspension E-Mailed
Dec 9, 2016
Suspension Letter Written
Nov 18, 2016
Teas/Email Correspondence Entered
Nov 17, 2016
Correspondence Received In Law Office
Nov 17, 2016
Teas Response To Office Action Received
May 17, 2016
Notification Of Non-Final Action E-Mailed
May 17, 2016
Non-Final Action E-Mailed
May 17, 2016
Non-Final Action Written
May 5, 2016
Assigned To Examiner
Apr 22, 2016
New Application Office Supplied Data Entered In Tram
Apr 22, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24